PMV PHARMACEUTICALS, INC. Income Taxes Paid
PMV PHARMACEUTICALS, INC. (PMVP) reported Income Taxes Paid of $2.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2024-02-29
- PMV PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2022-03-31 was $2.00K, a 50.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2021-09-30 was $19.00K, a 533.33% increase year-over-year.
- PMV PHARMACEUTICALS, INC. income taxes paid, net for the quarter ending 2021-06-30 was $0.00.
- PMV PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2021 was $23.00K, a 283.33% increase from fiscal 2020.
- PMV PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2020 was $6.00K, a 25.00% decline from fiscal 2019.
- PMV PHARMACEUTICALS, INC. income taxes paid, net for fiscal 2019 was $8.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-10 | $2.00K derived: sum of 2 quarters · filed 2024-02-29 | $21.00K derived: sum of 3 quarters · filed 2024-02-29 | $21.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $19.00K derived: sum of 2 quarters · filed 2024-02-29 | $19.00K derived: sum of 3 quarters · filed 2024-02-29 | $23.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $19.00K derived: sum of 2 quarters · filed 2022-11-08 | $23.00K 10-Q · filed 2022-11-08 | $24.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.00K 10-Q · filed 2022-08-09 | $5.00K derived: sum of 3 quarters · filed 2023-03-01 | $8.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-10 | $5.00K derived: sum of 2 quarters · filed 2023-03-01 | $8.00K derived: sum of 3 quarters · filed 2023-03-01 | $8.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.00K derived: sum of 2 quarters · filed 2023-03-01 | $4.00K derived: sum of 3 quarters · filed 2023-03-01 | $6.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $3.00K derived: sum of 2 quarters · filed 2021-11-12 | $5.00K 10-Q · filed 2021-11-12 | $5.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.00K 10-Q · filed 2021-08-13 | $2.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-14 | $2.00K derived: sum of 2 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $8.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |